PKM and lung carcinoma: Zhou et al. in their recent study where they investigated the effects of hiTDExs treatment on macrophages, demonstrated that hiTDExs secreted by lung cancer cells can carry PKM2 with oncogenic activity, thereby increase the proliferation and migration of lung cancer cells in vitro and enhance the tumor growth and metastasis of lung cancer cells in vivo.